Drug appears to slow down progression of Alzheimer’s

Drugs that could be the “first” to slow the progression of Alzheimer’s disease have been unveiled.

Researchers revealed the the promising results of studies into the use of solanezumab and aducanumab.

Results suggest that if given to patients early enough, the antibody therapies will be able to slow cognitive decline.